NCT04526782
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04526782
Title ENCOrafenib with Binimetinib in BRAF NSCLC (ENCO-BRAF)
Acronym ENCO-BRAF
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Intergroupe Francophone de Cancerologie Thoracique
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA